Kornelia Kotseva1,2, Guy De Backer2, Dirk De Bacquer3, Lars Rydén4, Arno Hoes5, Diederick Grobbee5, Aldo Maggioni6,7, Pedro Marques-Vidal8, Catriona Jennings2, Ana Abreu9, Carlos Aguiar10, Jolita Badariene11,12, Jan Bruthans13, Renata Cifkova13, Kairat Davletov14, Mirza Dilic15, Maryna Dolzhenko16, Dan Gaita17, Nina Gotcheva18, Hosam Hasan-Ali19, Piotr Jankowski20, Christos Lionis21, Silvia Mancas17, Davor Milićić22, Erkin Mirrakhimov23,24, Rafael Oganov25, Nana Pogosova26, Željko Reiner27, Duško Vulić28, David Wood2. 1. St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK. 2. National Institute for Prevention and Cardiovascular Health, National University of Ireland-Galway, Republic of Ireland. 3. Department of Public Health and Primary Care, Ghent University, Belgium. 4. Department of Medicine Solna, Karolinska Institutet, Sweden. 5. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands. 6. Maria Cecilia Hospital, GVMCare & Research Cotignola, Italy. 7. EURObservational Research Programme, European Society of Cardiology, France. 8. Department of Medicine, Lausanne University Hospital, Switzerland. 9. Hospital Santa Marta, Centro Hospitalar de Lisboa Central, Portugal. 10. Hospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Portugal. 11. Clinic of Cardiac and Vascular Diseases, Vilnius University, Lithuania. 12. Centre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Lithuania. 13. Center for Cardiovascular Prevention, Charles University in Prague, Czech Republic. 14. Health Research Institute, Al-Farabi Kazakh National University, Kazakhstan. 15. Medical Faculty, University of Sarajevo, Bosnia and Herzegovina. 16. Supyk National Medical Academy of Postgraduate Education, Ukraine. 17. Clinica de Recuperare Cardiovasculara, Universitatea de Medicina si Farmacie Victor Babes, Romania. 18. Department of Cardiology, National Heart Hospital, Bulgaria. 19. Cardiovascular Medicine Department, Assiut University, Egypt. 20. I Department of Cardiology, Interventional Electro-cardiology and Hypertension, Jagiellonian University Medical College, Poland. 21. Clinic of Social and Family Medicine, University of Crete, Greece. 22. School of Medicine, University of Zagreb, Croatia. 23. Kyrgyz State Medical Academy, Kyrgyzstan. 24. National Center of Cardiology and Internal Medicine named after academician Mirrakhimov MM, Kyrgyzstan. 25. National Research Center for Preventive Medicine, Russia. 26. National Medical Research Center of Cardiology, Ministry of Healthcare of the Russian Federation, Russia. 27. University Hospital Centre Zagreb, University of Zagreb, Croatia. 28. Faculty of Medicine, University of Banja Luka, Bosnia and Herzegovina.
Abstract
BACKGROUND: European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) V in primary care was carried out by the European Society of Cardiology EURObservational Research Programme in 2016-2018. The main objective was to determine whether the 2016 Joint European Societies' guidelines on cardiovascular disease prevention in people at high cardiovascular risk have been implemented in clinical practice. METHODS: The method used was a cross-stional survey in 78 centres from 16 European countries. Patients without a history of atherosclerotic cardiovascular disease either started on blood pressure and/or lipid and/or glucose lowering treatments were identified and interviewed ≥ 6 months after the start of medication. RESULTS: A total of 3562 medical records were reviewed and 2759 patients (57.6% women; mean age 59.0 ± 11.6 years) interviewed (interview rate 70.0%). The risk factor control was poor with 18.1% of patients being smokers, 43.5% obese (body mass index ≥30 kg/m2) and 63.8% centrally obese (waist circumference ≥88 cm for women, ≥102 cm for men). Of patients on blood pressure lowering medication 47.0% reached the target of <140/90 mm Hg (<140/85 mm Hg in people with diabetes). Among treated dyslipidaemic patients only 46.9% attained low density lipoprotein-cholesterol target of <2.6 mmol/l. Among people treated for type 2 diabetes mellitus, 65.2% achieved the HbA1c target of <7.0%. CONCLUSION: The primary care arm of the EUROASPIRE V survey revealed that large proportions of people at high cardiovascular disease risk have unhealthy lifestyles and inadequate control of blood pressure, lipids and diabetes. Thus, the potential to reduce the risk of future cardiovascular disease throughout Europe by improved preventive cardiology programmes is substantial. Published on behalf of the European Society of Cardiology. All rights reserved.
BACKGROUND: European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) V in primary care was carried out by the European Society of Cardiology EURObservational Research Programme in 2016-2018. The main objective was to determine whether the 2016 Joint European Societies' guidelines on cardiovascular disease prevention in people at high cardiovascular risk have been implemented in clinical practice. METHODS: The method used was a cross-stional survey in 78 centres from 16 European countries. Patients without a history of atherosclerotic cardiovascular disease either started on blood pressure and/or lipid and/or glucose lowering treatments were identified and interviewed ≥ 6 months after the start of medication. RESULTS: A total of 3562 medical records were reviewed and 2759 patients (57.6% women; mean age 59.0 ± 11.6 years) interviewed (interview rate 70.0%). The risk factor control was poor with 18.1% of patients being smokers, 43.5% obese (body mass index ≥30 kg/m2) and 63.8% centrally obese (waist circumference ≥88 cm for women, ≥102 cm for men). Of patients on blood pressure lowering medication 47.0% reached the target of <140/90 mm Hg (<140/85 mm Hg in people with diabetes). Among treated dyslipidaemic patients only 46.9% attained low density lipoprotein-cholesterol target of <2.6 mmol/l. Among people treated for type 2 diabetes mellitus, 65.2% achieved the HbA1c target of <7.0%. CONCLUSION: The primary care arm of the EUROASPIRE V survey revealed that large proportions of people at high cardiovascular disease risk have unhealthy lifestyles and inadequate control of blood pressure, lipids and diabetes. Thus, the potential to reduce the risk of future cardiovascular disease throughout Europe by improved preventive cardiology programmes is substantial. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: S Störk; P U Heuschmann; K Ungethüm; S Wiedmann; M Wagner; R Leyh; G Ertl; S Frantz; T Geisler; W Karmann; R Prondzinsky; C Herdeg; M Noutsias; T Ludwig; J Käs; B Klocke; J Krapp; D Wood; K Kotseva Journal: Clin Res Cardiol Date: 2022-09-27 Impact factor: 6.138
Authors: Pauline Cavagna; Méo Stéphane Ikama; Kouadio Euloge Kramoh; Jean Laurent Takombe; Ibrahima Bara Diop; Ibrahim Ali Toure; Dadhi M Balde; Anastase Dzudie; Beatriz Ferreira; Martin D Houenassi; Murielle Hounkponou; Adama Kane; Suzy G Kimbally-Kaki; Samuel Kingue; Charles Kouam Kouam; Emmanuel Limbole; Liliane Mfeukeu Kuate; Jean Bruno Mipinda; Roland N'guetta; Carol Nhavoto; Jean Marie Damorou; Abdallahi Sidy Ali; Bamba Gaye; Gabriel S Tajeu; Diane Macquart de Terline; Marie Cécile Perier; Michel Azizi; Xavier Jouven; Marie Antignac Journal: Eur J Prev Cardiol Date: 2021-09-20 Impact factor: 7.804
Authors: Ricardo Lopez Santi; Felipe Martinez; Adrian Baranchuk; Alvaro Sosa Liprandi; Daniel Piskorz; Alberto Lorenzatti; Maria Pilar Lopez Santi; Juan Carlos Kaski Journal: Eur Cardiol Date: 2021-04-27
Authors: Małgorzata Chlabicz; Jacek Jamiołkowski; Wojciech Łaguna; Paweł Sowa; Marlena Paniczko; Magda Łapińska; Małgorzata Szpakowicz; Natalia Drobek; Andrzej Raczkowski; Karol A Kamiński Journal: J Clin Med Date: 2021-04-09 Impact factor: 4.241